These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Reproducibility of heart rate variability in the chronic phase of myocardial infarction].
    Author: Brembilla-Perrot B, Houriez P, Jacquemin L, Houplon P, Claudon O, Danchin N.
    Journal: Arch Mal Coeur Vaiss; 1998 Feb; 91(2):245-52. PubMed ID: 9749252.
    Abstract:
    Evaluation of heart rate variability is a common method of assessing autonomic nervous system function and its effects on heart rate in different conditions. The reproducibility of the technique is not known in the chronic phase of myocardial infarction. The aim of this study was therefore to assess the reproducibility of the measurement in 54 subjects who were clinically stable with no change in treatment at a distance from acute or semi-recent (> 2 years) myocardial infarction, after an interval of one month. The temporal and spectral analysis of heart rate variability included measurement of the standard deviation of the normal RR intervals (SDNN), on the mean heart rate, the percentage of RR intervals greater than 50 ms than the adjacent interval (pNN50), the coefficient of variability (CV), the square root of the differences between successive RR intervals (rMSSD), the power of low frequencies (LF) and high frequencies (HF) and of the fractional spectral power (LF/HF). No significant changes in these parameters were observed. Analysis of individual variations showed that the heart rate was the most stable parameter: for evaluation of vagal tone, the rMSSD showed less variability than the pNN50 and HF. The presence of cardiac disease did not influence these results. The authors conclude that parameters of evaluation of heart rate variability in temporal and spectral analysis are globally reproducible in stable subjects. However, individual values may change from one measurement to another. Nevertheless, abnormal variability is constantly observed at the second investigation and, similarly, normal variability also remains unchanged. These individual variations suggest that, for the demonstration of change in these parameters of variability with treatment, large population groups must be studied.
    [Abstract] [Full Text] [Related] [New Search]